Floatz logo

Acetazolamide

Tumor Skin

Obsidian Therapeutics, Inc.Small moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Tumor Skin cohort.

Asset / SponsorPhaseRating
gsk1120212
TriHealth Inc.
Phase 2CCC
Dabrafenib
TriHealth Inc.
Phase 2CCC
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE
TriHealth Inc.
Phase 2CCC
Obx-115
Obsidian Therapeutics, Inc.
Phase 1/2CCC
Fludarabine
Obsidian Therapeutics, Inc.
Phase 1/2CCC
Oxygen
West Virginia University
N/AD

Same molecule, other indications

Acetazolamide is also rated in:

Obstructive Sleep ApneaDormant
BB
Indicative ·
67 / 100
View asset →
Metabolic AlkalosisDormant
B
Indicative ·
60 / 100
View asset →
Obesity Hypoventilation SyndromeDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →